Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 2/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | NAT1 | P18440 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | EEF2K | O00418 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27602989 | 1.00 | SLC1A3 (0.50) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| SCHEMBL6250944 | 1.00 | SLC1A3 (0.50) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| SCHEMBL4862904 | 0.99 | SLC1A3 (0.49) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| Benzene SCHEMBL4859490 | 0.99 | SLC1A3 (0.49) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| SCHEMBL4864326 | 0.99 | SLC1A3 (0.49) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| Benzene SCHEMBL4862827 | 0.99 | SLC1A3 (0.49) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| Hexamethylbenzene SCHEMBL4853475 | 0.96 | SLC1A3 (0.47) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| Hexamethylbenzene SCHEMBL4855090 | 0.96 | SLC1A3 (0.47) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| SCHEMBL4862869 | 0.95 | SLC1A3 (0.46) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 | |
| SCHEMBL4862026 | 0.95 | SLC1A3 (0.46) | SLC1A3SLC1A2SLC1A1NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399895-B1 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-9896402-B2 | Method for preventing decrease in optical purity | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-02-20 | — | — | US | disclosed |
| EP-2774908-B1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | TAKASAGO PERFUMERY CO LTD (JP) | 2017-02-08 | — | — | EP | disclosed |
| US-9162934-B2 | Process for producing optically active alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20140296582-A1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2774908-A1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | Takasago International Corporation (JP) | 2014-09-10 | — | — | EP | disclosed |
| EP-2394977-B1 | Process for producing optically active alcohol | KANTO KAGAKU (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8558033-B2 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2013-10-15 | — | — | US | disclosed |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2399895-A2 | Process for producing optically active aliphatic fluoroalcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-28 | — | — | EP | disclosed |
| US-7332622-B2 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGUKU KABUSHIKI KAISHA (JP) | 2008-02-19 | — | — | US | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| US-7268250-B2 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2007-09-11 | — | — | US | disclosed |
| EP-1439159-B1 | Process for producing optically active compound | KANTO KAGAKU (JP) | 2007-06-20 | — | — | EP | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
| CN-1626501-A | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU (JP) | 2005-06-15 | — | — | CN | disclosed |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-1512678-A1 | Process for preparing optically active nitro compounds and cyano compounds | Kanto Kagaku Kabushiki Kaisha (JP) | 2005-03-09 | — | — | EP | disclosed |
| US-20040176616-A1 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA | 2004-09-09 | — | — | US | disclosed |
| EP-1439159-A1 | Process for producing optically active compound | Kanto Kagaku Kabushiki Kaisha (JP) | 2004-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | SLC1A3 4846/4885SLC1A2 4735/4885SLC1A1 4824/4885 |
| US-20140296582-A1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | QDPR, NOX4, NOX5 | SLC1A3 4768/4885SLC1A2 4840/4885SLC1A1 4831/4885 |
| US-20040176616-A1 | Process for producing optically active compound | OSTC, NPEPPS, PPOX | SLC1A3 4283/4885SLC1A2 4469/4885SLC1A1 4552/4885 |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | NOS1, NOS2, NOX1 | SLC1A3 1768/4885SLC1A2 1595/4885SLC1A1 1447/4885 |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | ADH1A, ADH1C, ADH5 | SLC1A3 2827/4885SLC1A2 2106/4885SLC1A1 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.